Evidence map›Paper›PMID 32197103›Full record

ArticleLancet (London, England)2020

COVID-19: towards controlling of a pandemic.

Juliet Bedford, Delia Enria, Johan Giesecke, David L Heymann, Chikwe Ihekweazu, Gary Kobinger, H Clifford Lane, Ziad Memish, Myoung-Don Oh, Amadou Alpha Sall and 4 more

4 registry-linked trialsAbstract read
In one paragraph

Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 684 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
684citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04386798 nacompletednot on this map

Determination of Stress and Anxiety Levels of Mothers Lying in the Newborn Intensive Care Unit During Coronavirus Disease Pandemic Period

TypeinterventionalSponsorEskisehir Osmangazi UniversityRan2020 to 2021Enrolled105ConditionsNewborn, AnxietyArmssurvey work
NCT05146609 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Acceptance of Hepatitis C Screening by Self-testing in High Risk and General Population

TypeinterventionalSponsorUniversity of La LagunaRan2022 to 2024Enrolled1,384ConditionsHepatitis CArmsScreening HCV. HR-HOSPITAL, Screening HCV. HR-DDP, Screening HCV. GP-HOSPITAL, Screening HCV. GP-PCC
NCT05190016 completednot on this mapstarted 2022, after this paper: background citation

Development of a Multiplex BangasureTM RT-PCR Kit for the Detection of SARS-Corona Virus-2

Typeobservational_patient_registrySponsorDR. MALA KHANRan2022 to 2022Enrolled150ConditionsCOVID-19
NCT05756738 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Acceptance and Feasibility of Hepatitis c Screening Strategies in Social Insertion Centers With Alternative Sentences to Prison and Open System

TypeinterventionalSponsorUniversity of La LagunaRan2023 to 2024Enrolled854ConditionsHepatitis C VirusArmsDried blood spot testing
3 · Its place in the literature

Who cites it

684 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Innate immunity to SARS-CoV-2 infection: a review.Epidemiology and infection · 2022
    Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Risk Calibration: Divergent Interpretations of Risk Assessment in Norway's Early COVID-19 Response.Risk analysis : an official publication of the Society for Risk Analysis · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

624 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Juliet BedfordAnthrologica, Oxfordshire, UK.
Delia EnriaInstituto Nacional de Enfermedades Virales Humanas (INEVH) "Julio Maiztegui" and CCWHO-OPS on Viral Haemorrhagic Fevers and Arboviruses, Buenos Aires, Argentina.
Johan GieseckeKarolinska Institute, Stockholm, Sweden.
David L HeymannInfectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK. Electronic address: david.heymann@lshtm.ac.uk.
Chikwe IhekweazuNigeria Centre for Disease Control, Abuja, Nigeria.
Gary KobingerInfectious Disease Research Centre, Université Laval, Faculty of Medicine, Québec City, Canada.
H Clifford LaneNational Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Ziad MemishResearch and Innovation Center, King Saud Medical City, Ministry of Health, Riyadh, Saudi Arabia.
Myoung-Don OhJ W Lee Center for Global Medicine, SNU College of Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
Amadou Alpha SallInstitut Pasteur de Dakar, Dakar, Senegal.
Anne SchuchatCenters for Disease Control and Prevention, Atlanta, GA, USA.
Kumnuan UngchusakMinistry of Health, Department of Diseases Control, Bangkok, Thailand.
Lothar H WielerRobert Koch Institute, Berlin, Germany.
WHO Strategic and Technical Advisory Group for Infectious Hazards

Funding

Pathogenesis, Treatment and Prevention of Emerging Infectious DiseasesZIAAI000936 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LANE, CLIFFORD · 2009 to 2025
$6.4M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BetacoronavirusCivil DefenseCoronavirus InfectionsPandemicsPneumonia, ViralRisk AssessmentAge FactorsAneurysm, InfectedComorbidityContact TracingCOVID-19Developing CountriesFinancial SupportHumansPatient IsolationPopulation Surveillance

Identifiers

PMID32197103
PMCPMC7270596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.